---
title: "INFU: Record revenue and margin gains fueled by Oncology and wound care growth, with positive outlook"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294840749.md"
description: "Record quarterly revenue and margin expansion were driven by strong Oncology and wound care growth, with significant margin improvement from the GE HealthCare contract restructuring. Outlook remains positive, with continued growth expected in core segments and stable EBITDA margins.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-04T14:31:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294840749.md)
  - [en](https://longbridge.com/en/news/294840749.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294840749.md)
generator: "portal-rs"
---

# INFU: Record revenue and margin gains fueled by Oncology and wound care growth, with positive outlook

Record quarterly revenue and margin expansion were driven by strong Oncology and wound care growth, with significant margin improvement from the GE HealthCare contract restructuring. Outlook remains positive, with continued growth expected in core segments and stable EBITDA margins.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [INFU.US](https://longbridge.com/en/quote/INFU.US.md)
- [GEHC.US](https://longbridge.com/en/quote/GEHC.US.md)

## Related News & Research

- [Corcept names Roberto Vieira as President, Oncology in initial beneficial ownership filing](https://longbridge.com/en/news/297971867.md)
- [AI in Virtual Medical Assistant Market to Reach US$ 12.3 Bn by 2031, Growing at 36.5% CAGR, New Report by Wissen Research](https://longbridge.com/en/news/298618482.md)
- [STX: HAMR technology and AI-driven demand are driving strong exabyte growth and margin expansion](https://longbridge.com/en/news/298632678.md)
- [Sam Altman says AI needs to do more than cure cancer to win over skeptics](https://longbridge.com/en/news/298040546.md)
- [Medicus Pharma pivots to precision oncology, prioritizing CD228V melanoma proof-of-concept study](https://longbridge.com/en/news/298310825.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**